Vitamin K2 Intermediates

Patent No. EP3018116 (titled "Vitamin K2 Intermediates") was filed by Kappa Bioscience on Sep 24, 2009. The application was issued on Oct 28, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LESAFFREJul 27, 2021BANDPAY & GREUTER
NATTOPHARMA ASAJul 27, 2021WEICKMANN & WEICKMANN PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3018116

KAPPA BIOSCIENCE
Application Number
EP15193746A
Filing Date
Sep 24, 2009
Status
Revoked
Aug 4, 2023
Publication Date
Oct 28, 2020